Alg8 Congenital Disorder Of Glycosylation C2931002
A rare genetic disorder that impairs how cells add sugar molecules to proteins. It usually appears in early childhood with developmental delays, liver problems, and neurological symptoms. Care is primarily supportive, addressing each person's specific needs.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Chronic diarrhea
(metabolic)Fatigue or weight changes
(metabolic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Coagulation abnormalities
(metabolic)Seizures
(metabolic)Hepatic fibrosis
(metabolic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Enteral Feeding Support
Implementation of enteral nutrition support including nasogastric or gastrostomy tube feeding when oral intake is insufficient. Customized formula selection based on metabolic needs and tolerance assessments.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Comprehensive Organ Function Surveillance
Systematic monitoring of hepatic, cardiac, renal, and coagulation function through regular laboratory testing and imaging studies. Early detection of complications allows for proactive intervention.
Additional treatment options
Targeted Symptom Pharmacotherapy
Individualized medication regimen addressing specific manifestations including gastrointestinal symptoms, seizures, and bleeding tendency. Regular medication reviews ensure optimal dosing and minimize adverse effects.
medicationNeuromotor Development Program
Structured physical therapy program targeting hypotonia, ataxia, and developmental delays. Includes progressive strengthening exercises, balance training, and functional mobility practice.
physical_therapyCorrective Surgical Interventions
Surgical management when indicated for anatomical complications such as cardiac defects, skeletal abnormalities, or placement of feeding devices. Requires multidisciplinary planning and perioperative CDG-specific protocols.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Alg8 Congenital Disorder Of Glycosylation C2931002?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Alg8 Congenital Disorder Of Glycosylation C2931002. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy